课题基金 / 基金详情

Molecular & Behavioral Effects of Low Level Mn Exposure

Molecular & Behavioral Effects of Low Level Mn Exposure
分子
批准号:
8274461
负责人:
Tomas R Guilarte
金额:
$76.6万
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-02-18 至 2014-04-30
关键词:
AffectAlzheimer&aposs DiseaseAmphetaminesAmyloidAnimalsAreaAttentionAutomobilesBasal GangliaBehaviorBehavior assessmentBehavioralBrainBrain ChemistryBrain regionCellular Stress ResponseChronicCognitiveCognitive deficitsCollaborationsCorpus striatum structureDRD2 geneDataDiffuseDiffusion Magnetic Resonance ImagingDopamineDopamine ReceptorDoseEnvironmentEvaluationEvolutionExposure toFunctional disorderFundingFutureGasolineGeneral PopulationGlobus PallidusGlutamatesGoalsGuidelinesHeadHealthHealth PolicyHumanImageImaging TechniquesImpaired cognitionImpairmentKnowledgeLearningLifeLinkMagnetic Resonance ImagingMagnetic Resonance SpectroscopyManganeseMeasuresMedialMediatingMemoryMetalsModalityMolecularMonitorMonkeysMotorNerve DegenerationNeurobiologyNeurologicNeurologic DysfunctionsNeuronsNeurosciencesOccupationalOutputParietalParietal LobePathologyPatientsPlayPopulationPositronProgress ReportsPsyche structurePublic HealthResearch DesignResolutionRoleSamplingSchizophreniaScientistSourceStructureStructure of subthalamic nucleusSubstantia nigra structureSynapsesSystemTemporal LobeTestingTimeToxic Environmental SubstancesToxinUnited States National Institutes of HealthWorkage relatedaging brainanthropogenesisbasebehavior testdopamine transporterexecutive functionfrontal lobeimprovedin vivomolecular imagingnervous system disorderneurobehavioralneurochemistryneuroimagingneuropathologyneurotoxicityneurotoxicologyneurotransmissionnonhuman primatenovelprocessing speedputamenradioligandsynucleintomographytoolvigilancevisual learningvisual memorywhite matter

项目摘要

项目成果

Tomas R Guilarte的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Manganese (Mn) is an essential metal for human health, but exposure to excess levels can cause neurological disease. Emerging evidence suggests that long-term exposures to low levels of anthropogenic or environmental sources of Mn may have detrimental effects on human neurological health. Automobile combustion of gasoline containing methylcyclopentadienyl manganese tricarbonyl (MMT) has the potential to significantly increase Mn exposures to human populations where this fuel additive is used. However, there is a paucity of knowledge on the neurological health effects of chronic exposures to low-levels of Mn. While moderate to high levels of Mn exposure are associated with motor abnormalities and cognitive dysfunction as well as basal ganglia dopaminergic dysfunction in humans and non-human primates. The extent to which lower levels of Mn exposure may target specific cognitive domains and alter brain chemistry is not known. The studies described in this application are the result of a unique and productive on-going collaboration of scientists with expertise in behavioral neuroscience, molecular imaging, molecular and cellular neuroscience, neurotoxicology, neurochemistry and neuropathology applying the latest state-of-the-art behavioral and neuroimaging modalities to understand the behavioral dysfunction and underlying molecular and cellular mechanisms of Mn-induced neurological disease in the living non-human primate brain. Our most recent evidence suggests that chronic low level Mn exposure in non-human primates produces in vivo neurochemical changes resembling those in schizophrenia patients. Further, exposure to Mn produces a cellular stress response and diffuse amyloid-2 plaques in the frontal cortex resembling those in the aging brain and in Alzheimer's disease. These preliminary findings provide a putative link of exposure to an environmental toxicant (Mn) and neurochemical and neuropathological changes associated with mental and neurological diseases. The proposed studies will expand on these findings and provide the most comprehensive assessment to date on the neurological consequences of chronic Mn exposure on the non-human primate brain. The knowledge gained will help set future public health policies and guidelines to limit Mn exposures in occupational settings and to the general population. Relevance: The work that we describe in this proposal will define the behavioral, in vivo neurochemistry and neuropathological effects at increasingly lower levels of chronic Mn exposure in non-human primates. They represent the most comprehensive assessment to date on the neurological consequences of chronic exposure to levels of Mn that segments of the population are likely to encounter in their environment. These studies have already provided novel findings and the knowledge gained will help set future public health policies and guidelines to limit Mn exposures in occupational settings and to the general population. PUBLIC HEALTH RELEVANCE: The long-term goal of the proposed studies is to determine the behavioral, neuroimaging and neuropathological effects of chronic exposure to increasingly lower concentrations of manganese (Mn) in order to identify the level of cumulative exposure that produces the earliest changes in behavior and brain chemistry. The ultimate goal is to determine the extent to which chronic exposure to environmentally- or occupationally- relevant levels of Mn contributes to human neurological disease. A major advantage of our unique collaboration is that behavioral and in vivo brain chemistry changes are monitored prospectively and in parallel with Mn exposure in non-human primates.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
TSPO and Neuroinflammation in Alzheimer's Disease
  • 批准号:
    10505310
  • 项目类别:
  • 资助金额:
    $36.88万
  • 财政年份:
    2022
  • 负责人:
    Tomas R Guilarte
  • 依托单位:
Peripheral BDZ Receptor - Biomarker of Neurotoxicity
  • 批准号:
    10020410
  • 项目类别:
  • 资助金额:
    $46.26万
  • 财政年份:
    2019
  • 负责人:
    Tomas R Guilarte
  • 依托单位:
Peripheral BDZ Receptor - Biomarker of Neurotoxicity
  • 批准号:
    10176485
  • 项目类别:
  • 资助金额:
    $46.26万
  • 财政年份:
    2019
  • 负责人:
    Tomas R Guilarte
  • 依托单位:
Peripheral BDZ Receptor - Biomarker of Neurotoxicity
  • 批准号:
    10414054
  • 项目类别:
  • 资助金额:
    $46.26万
  • 财政年份:
    2019
  • 负责人:
    Tomas R Guilarte
  • 依托单位: